With a fresh endorsement from the FDA, Johnson & Johnson has rounded out Tremfya’s presence in inflammatory bowel disease ...

Over the last six years, three GLP-1 drugs have been approved for children aged 10 and older with Type 2 diabetes. | Over the ...

After swiftly developing its COVID-19 vaccine in 2020 and launching it late that year, Moderna soon found itself facing ...

Nearly three years after originating the role, Erica Taylor, Ph.D., is stepping down as chief marketing officer of Genentech.

After Madison Norman graduated with an undergraduate degree in business administration from Boston University and then a ...

That’s according to Will Reese, chief innovation officer at Inizio Evoke, who spoke with Fierce Pharma Marketing during last ...

MilliporeSigma, a unit of Germany's Merck KGaA, opened a 150 million euro ($177 million) filtration products plant in Cork, ...

Trust in pharma has always been fragile, and the rise of misinformation has made it even more precarious. | Freda Lewis-Hall, ...

Merck & Co. is stepping up to the plate to raise awareness of the dangers of high LDL cholesterol and how it can increase the ...

AI is now the first place people go to for answers,” according to Jesse Wolfersberger, global lead of I/O Health at Weber Shandwick. | As AI plays an increasingly important role in health and pharma ...

After reaching the summit in a yearslong mission of introducing Takeda’s plasma-derived therapies (PDTs) to the market in its home country of Japan, Takeda team members started mapping out their ne | ...

Europe offers major opportunities for biotech and pharmaceutical companies, but breaking into the market is complicated by a patchwork of regulations, reimbursement systems and distribution networks.